Pressmeddelande

BioStock: Arcede proceeds to stability study in collaboration with Iconovo

Cision Publicerad: 20 Nov 2023 08:15

Lund-based Arcede Pharma continues to advance its project with RCD405. The company recently concluded the toxicology program and can now announce that the collaboration on the formulation work with Iconovo is progressing with good results. The formulation work has been completed and the next step will be to conduct a technical stability study and then take the drug candidate into the clinic.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/11/arcede-proceeds-to-stability-study-in-collaboration-with-iconovo/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Arcede Pharma

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!